See also this year's filing and all EDGAR filings for this company.
PDF Report 0001763950_2023_Lantern_Pharma_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001763950, Lantern Pharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 58,722,737 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 48,008 |
| 3 | remainder_Assets | 65,576 |
| 4 | LiabilitiesCurrent | 2,798,297 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,829,799 |
| 9 | ResearchAndDevelopmentExpense | 8,602,954 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 172,807 |
| 13 | remainder_ComprehensiveNetIncome | -278,697 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 58,836,321 |
| 1 | Liabilities | 2,798,297 |
| 2 | Expenses | 14,432,753 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 56,038,024 |
| 5 | NetIncome | -14,259,946 |
| 6 | ComprehensiveNetIncome | -14,399,294 |
| 7 | BaseVar | 38,259,438 |
| 8 | EconomicCapitalRatio | 2.66 |
Edgar->Model Mapping
Feature Distribution
Change over Time
